Hangzhou Synrx Therapeutics Technology Co. Ltd. has divulged crystalline salts of DNA polymerase θ (POLθ) inhibitors reported to be useful for the treatment of cancer.

Hangzhou Baicreat Pharma-Tech Co. Ltd. has identified DNA polymerase θ (POLθ) inhibitors reported to be useful for the treatment of cancer.

Alicorn Pharmaceutical Co. Ltd. has divulged new DNA polymerase θ (POLθ; POLQ) inhibitors reported to be useful for the treatment of cancer.

Shanghai Apeiron Biotechnology Co. Ltd. has reported selenium-containing heterocyclic compounds acting as DNA polymerase theta (POLθ, POLQ) inhibitors potentially useful for the treatment of cancer.

Chengdu Kanghong Pharmaceutical Co. Ltd. has identified DNA polymerase θ (POLθ) inhibitors reported to be useful for the treatment of cancer.

Repare Therapeutics Inc. has identified prodrugs acting as DNA polymerase θ (POLθ) inhibitors reported to be useful for the treatment of cancer.

Quantx Biosciences US Inc. has synthesized DNA polymerase θ (POLQ) inhibitors reported to be useful for the treatment of cancer.

Daewoong Pharmaceutical Co. Ltd. has divulged DNA polymerase θ (POLθ) inhibitors reported to be useful for the treatment of cancer.

Daewoong Pharmaceutical Co. Ltd. has identified DNA polymerase θ (POLQ, POLθ) inhibitors reported to be useful for the treatment of cancer.

Breakpoint Therapeutics GmbH patents describe new DNA polymerase θ (POLQ, POLθ) inhibitors potentially useful for the treatment of cancer.